Your browser doesn't support javascript.
loading
Phase II clinical trial of CD34+ cell therapy to explore endpoint selection and timing in patients with critical limb ischemia.
Fujita, Yasuyuki; Kinoshita, Makoto; Furukawa, Yutaka; Nagano, Tohru; Hashimoto, Hisako; Hirami, Yasuhiko; Kurimoto, Yasuo; Arakawa, Kyosuke; Yamazaki, Kazuo; Okada, Yukikatsu; Katakami, Nobuyuki; Uno, Emiko; Matsubara, Yoshihiro; Fukushima, Masanori; Nada, Adel; Losordo, Douglas W; Asahara, Takayuki; Okita, Yutaka; Kawamoto, Atsuhiko.
Affiliation
  • Fujita Y; Division of Vascular Regeneration, Unit of Regenerative Medicine, Institute of Biomedical Research and Innovation.
Circ J ; 78(2): 490-501, 2014.
Article in En | MEDLINE | ID: mdl-24257136
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pain / Stem Cells / Antigens, CD34 / Lower Extremity / Stem Cell Transplantation / Pain Management / Ischemia Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Circ J Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2014 Document type: Article Country of publication: Japan
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pain / Stem Cells / Antigens, CD34 / Lower Extremity / Stem Cell Transplantation / Pain Management / Ischemia Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Circ J Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2014 Document type: Article Country of publication: Japan